Fundamentals

Valuation

Metric	Q1	Q2	Δ in %
EV/EBITDA	57.23	-38.83	-90.80
Graham Fair Price	41.42	1.62	1.15
PEG	-82.30	< 0.005	0.04
Price/Book	17.39	0.26	0.22
Price/Cash Flow	36.76	-8.87	-14.03
Prices/Earnings	41.30	-0.60	-1.02
Price/Sales	-41.30	2.71	4.62
Price/FCF	36.76	-8.87	-14.03
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q1	Q2	Δ in %
Gross Profit Margin	-24.73	0.17	0.23
Operating Margin	-15.18	-0.24	-0.21
ROA	-100.00	-0.07	-0.03
ROE	-0.05	-0.11	-100.00
ROIC	< 0.005	-0.02	-69.41
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q1	Q2	Δ in %
Debt QOQ	0.01	0.07	-82.60
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-1.96	-1.30	33.48
EPS QOQ	0.28	-0.94	231.68
FCF QOQ	0.42	-0.86	105.40
Revenue QOQ	-0.51	1.00	94.99
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q1	Q2	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	179.83	83.83	-53.38
Days Sales Outstanding (DSO)	72.87	105.74	45.11
Inventory Turnover	0.50	1.07	114.52
Debt/Capitalization	0.24	0.24	0.98
Quick Ratio	0.15	0.40	161.44
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q1	Q2	Δ in %
Book Value	1.03	1.03	< 0.005
Cash	< 0.005	< 0.005	< 0.005
Capex	< 0.005	< 0.005	-100.00
Free Cash Flow	-0.02	-0.03	-85.62
Revenue	0.05	0.10	100.00
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q1	Q2	Δ in %
Current Ratio	1.27	1.27	0.00
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-52.87	-21.20	59.89
Naive Interpretation	Member

06 - Financial Health · Weak

Rating